Advertisement

Topics

The German Breast Group and Celgene Corporation Company Profile

10:58 EST 15th December 2017 | BioPortfolio

GBG is a large independent academic network of over 500 study centers in Germany with the world- wide largest experience in conducting neoadjuvant breast cancer trials. Since 1998, with joined forces from AGO-B, over 10.000 patients participated in the neoadjuvant “Gepardo” trial series. GBG has recruited at totality of over 35.000 patients to trials in breast cancer of all indications. Reports on these trials were previously published in the New England Journal of Medicine, The Lancet Oncology, the Journal of Clinical Oncology and the Journal of the National Cancer Institute (for more information go to www.germanbreastgroup.de). The GBG Research Institute received unrestricted grants and the provision of medication from Celgene and Roche for the conduct of the GeparSepto study. ABRAXANE is approved in the US and Europe for patients with metastatic breast cancer.


News Articles [2663 Associated News Articles listed on BioPortfolio]

Genomic Health Release: New Analysis From German Study Group Prospective Trial Shows Minimal Distant Recurrence In Patients With Clinically High-Risk Breast Cancer And Low Oncotype DX Breast Recurrence Score?? Results Following Five Years Of Hormone Thera

  Life Sciences Jobs   ...

German FinTech Company NAGA Group to Launch Token Pre-Sale

Founded in 2015, The NAGA Group AG broke records earlier this year, launching the fastest-performing German IPO in the last 15 years. Listed on the Read more...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

MorphoSys AG: Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act]

MorphoSys AG / Preliminary announcement on the disclosure of financial statements 11.12.2017 / 16:47 Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 3...

Schlegel: Celgene-Kursrutsch gute Einstiegschance

Die Aktie von Celgene ist im Oktober heftig abgestürzt. Gründe waren unter anderem schlechte Studienergebnisse und eine Prognosesenkung. "Man muss aber sagen, Celgene hat wirklich noch eine sehr, s....

Health2047 Partners With Celgene to Enhance Data Liquidity in Healthcare

Health2047, a Silicon Valley-based healthcare innovation enterprise has announced a partnership with Celgene Corporation to develop a new data transfer protocol for healthcare that will be secure, tru...

BAM, UBA and BfR in US to promote careers in German departmental research

(BfR Federal Institute for Risk Assessment) Together with the Bundesanstalt für Materialforschung und -prüfung and the German Environment Agency, the German Federal Institute for Risk Assessment wil...

PubMed Articles [4623 Associated PubMed Articles listed on BioPortfolio]

Prognostic value of sequencing of radiotherapy and chemotherapy following breast-conserving surgery for patients with breast cancer.

Objective: To evaluate the prognostic value of sequencing of adjuvant radiotherapy and chemotherapy following breast-conserving surgery for patients with breast cancer. Methods: A total of 1 154 patie...

First international consensus conference on standardization of oncoplastic breast conserving surgery.

To obtain consensus recommendations for the standardization of oncoplastic breast conserving surgery (OPS) from an international panel of experts in breast surgery including delegates from the German,...

Primary Pediatric Breast Lesions: Comparing the Prevalence of Malignancies in the Middle East with North America; Review of 1031 Cases.

Benign breast masses are uncommon but are becoming more recognized among the pediatric population. Malignant breast lesions are very rare. The aim of our study was to review and compare the demographi...

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.

This study describes comprehensive data from a breast cancer registry concerning the use of endocrine treatment (ET) and chemotherapy in the first, second and higher therapy lines in hormone receptor ...

Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer.

The association of uterine leiomyoma with increased risk of breast cancer is controversial. Therefore, we used the National Health Insurance Research Database of Taiwan to examine breast cancer incide...

Clinical Trials [7529 Associated Clinical Trials listed on BioPortfolio]

Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults

The purpose of this study is to test and compare the allergenic effects of three commercially available German cockroach allergen extracts in adults. Study hypothesis: The biological pote...

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Multi-center, survival data collection in subjects previously enrolled in Celgene Protocol CC-5013-MDS-003.

Registry for Acute Pain Treatment

The German Network for acute pain management and Regional Anesthesia (NRA) is a multi-center, non-interventional registry and benchmark project, assessing and analysing clinical and patien...

Responsiveness of the German Version of the Neck Disability Index (NDI-G)

This study evaluates if the German Version of the NDI is sensitive to change over time.

Registry of the German CLL Study Group

Long term follow-up of patients with CLL, B-PLL, T-PLL, SLL, T or NK-LGL, HCL and Richter's transformation

Companies [2214 Associated Companies listed on BioPortfolio]

The German Breast Group and Celgene Corporation

GBG is a large independent academic network of over 500 study centers in Germany with the world- wide largest experience in conducting neoadjuvant breast cancer trials. Since 1998...

Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. C...

Celgene Cellular Therapeutics

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. ...

German Breast Group

The German Breast Group

More Information about "The German Breast Group and Celgene Corporation" on BioPortfolio

We have published hundreds of The German Breast Group and Celgene Corporation news stories on BioPortfolio along with dozens of The German Breast Group and Celgene Corporation Clinical Trials and PubMed Articles about The German Breast Group and Celgene Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The German Breast Group and Celgene Corporation Companies in our database. You can also find out about relevant The German Breast Group and Celgene Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record